Supplemental Financial Information


		2025		2024		2023
Accounts and notes receivable
Trade receivables		$	9,265	$	8,487
Other receivables		2,471		2,202
Total		11,736		10,689
Allowance, beginning of year		356		175		$	150
Net amounts charged to expense (a)		61		228		55
Deductions		(55)		(36)		(26)
Translation and other (a)		(132)		(11)		(4)
Allowance, end of year		230		356		$	175
Accounts and notes receivable, net		$	11,506	$	10,333

Property, plant and equipment, net	Average Useful Life (Years)
Land		$	1,110	$	1,136
Buildings and improvements	15 - 44	13,875		11,938
Machinery and equipment, including fleet and software	5 - 15	41,113		36,990
Construction in progress		4,811		5,941
		60,909		56,005
Accumulated depreciation		(31,004)		(27,997)
Property, plant and equipment, net		$	29,905	$	28,008
Depreciation expense		$	3,213	$	2,945	$	2,714

Other assets
Noncurrent notes and accounts receivable		$	136	$	111
Deferred marketplace spending		205		100
Pension plans		1,449		1,190
Right-of-use assets		3,745		3,383
Other investments (b)		2,526		1,346
Other		923		821
Total		$	8,984	$	6,951



Accounts payable and other current liabilities
Accounts payable (c)		$	11,704	$	10,997
Accrued marketplace spending		3,512		3,458
Accrued compensation and benefits		2,230		2,256
Dividends payable		1,967		1,885
Current lease liabilities		719		642
Other current liabilities (d)		5,771		5,216
Total		$	25,903	$	24,454

(a)In 2024, we recognized an allowance for expected credit losses related to outstanding receivables from TBG associated with the Juice Transaction. In 2025, the outstanding receivables and related allowance were reclassified to noncurrent notes and accounts receivable. See Note 1 for further information.

(b)Includes our investment in Celsius convertible preferred stock. See Note 9 for further information.

(c)Increase primarily reflects timing of payments and currency translation adjustments, partially offset by a decrease in capital expenditure payables.

(d)Increase primarily reflects acquisition of poppi. See Note 13 for further information on acquisitions.

Statement of Cash Flows


	2025		2024		2023
Interest paid	$	1,748	$	1,585	$	1,401
Income taxes paid, net of refunds (a)	$	3,083	$	3,064	$	2,532

(a)Includes tax payments of $772 million in 2025, $579 million in 2024 and $309 million in 2023 related to the TCJ Act.

Supplemental Non-Cash Activity


	2025		2024		2023
Debt discharged via legal defeasance	$	—	$	—	$	94
Investment obtained for certain assets (see Notes 4 and 9)	$	554	$	—	$	—

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:


	2025		2024
Cash and cash equivalents	$	9,159	$	8,505

Restricted cash included in other assets (a)	45		48
Total cash and cash equivalents and restricted cash	$	9,204	$	8,553

(a)Primarily relates to collateral posted against certain of our derivative positions.